Log in to search using one of your social media accounts:

 

Symptomatic AF and Risk of Cardiovascular Events Symptomatic AF and Risk of Cardiovascular Events
Is persistence or development of symptoms, despite medical treatment, an independent prognostic marker in atrial fibrillation?Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 11, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Cirrhosis Is a Risk Factor for Atrial Fibrillation Cirrhosis Is a Risk Factor for Atrial Fibrillation
Is cirrhosis an independent risk factor for development of atrial fibrillation?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 10, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Does older age increase the risk of atrial fibrillation?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - January 10, 2018 Category: Consumer Health News Source Type: news

CardioFocus expands HeartLight partnership deal with Japan Lifeline
CardioFocus said today it is expanding its partnership deal with Japan Lifeline to increase the scope of its Japanese commercialization efforts and to explore commercialization of its HeartLight System in other Asia Pacific markets. The Marlborough, Mass.-based company’s HeartLight system is designed to allow electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with a high procedural flexibility. The device includes a compliant balloon to accommodate diverse PV anatomies and has a short learning curve to allow for quick adoption of the tech, the c...
Source: Mass Device - January 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular CardioFocus Inc. Source Type: news

Avoidable cardiac deaths as women receive different treatment
Women have three times higher excess mortality in year after heart attack Related items fromOnMedica Atrial fibrillation poses greater risk for women than men Heart rehabilitation services neglect women Migraines linked to cardiovascular disease and death in women Heavy drinking is bad for women's hearts Hospitals fail women with myocardial infarction (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 8, 2018 Category: UK Health Source Type: news

ECG Screening Gains No Traction in Draft USPSTF Recommendations ECG Screening Gains No Traction in Draft USPSTF Recommendations
Citing a paucity of data, the task force did not commit itself on ECG screening for atrial fibrillation in low-risk seniors and retained a recommendation against its use for CVD in low-risk adults.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 5, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

NOACs for Atrial Fibrillation: Important Drug/Drug Interactions NOACs for Atrial Fibrillation: Important Drug/Drug Interactions
What drugs have important interactions with direct Xa and direct thrombin inhibitors?Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2018 Category: Consumer Health News Tags: Internal Medicine Clinical Case Source Type: news

Atrial fibrillation more deadly in rural U.S. hospitals
(Reuters Health) - - Among U.S. patients hospitalized for the common heart rhythm disorder known as atrial fibrillation, those in rural areas may be more likely to die than their urban counterparts, a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - January 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

NOACs and Prescribing Practices for AF in Older Adults NOACs and Prescribing Practices for AF in Older Adults
Has the introduction of several new oral anticoagulants changed anticoagulation prescribing practices for older adults with atrial fibrillation?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Acute Stress and Abnormal Left Atrial Electrophysiology Acute Stress and Abnormal Left Atrial Electrophysiology
What might be the mechanism by which acute mental stress triggers atrial fibrillation?Journal of Cardiovascular Electrophysiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 26, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Friday Feedback: Pros, Cons of Routine ECG Screening for Asymptomatic Patients
(MedPage Today) -- USPSTF doesn't support routine screening for atrial fibrillation, overall cardiovascular disease (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - December 22, 2017 Category: Neurology Source Type: news

Report: Apple is working on an in-house Apple Watch ECG to compete with AliveCor ’ s Kardiaband
Apple (NSDQ:AAPL) is reportedly developing an in-house ECG for its Apple Watch that would compete with the recently approved KardiaBand made by AliveCor. The Apple ECG, which is still being testing, involves smartwatch users squeezing the frame of the device with the opposite hand, allowing Apple Watch to pass an imperceptible current across the chest to assess heart rhythm, according to Bloomberg, which cited “people familiar with the plan.” Last month the FDA cleared AliveCor’s KardiaBand ECG device for the Apple Watch, designed to monitor for early signs of atrial fibrillation. First int...
Source: Mass Device - December 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular mHealth (Mobile Health) Wall Street Beat AliveCor Apple Source Type: news

USPSTF Examines ECG Screening to Prevent CVD Events, AFib
On Dec. 19, the U.S. Preventive Services Task Force posted a pair of draft recommendations on electrocardiographic screening for cardiovascular disease and atrial fibrillation. (Source: AAFP News)
Source: AAFP News - December 20, 2017 Category: Primary Care Source Type: news

USPSTF Doesn't Endorse Routine ECG for Atrial Fibrillation Detection or CVD Prevention
The U.S. Preventive Services Task Force does not endorse electrocardiography (ECG) screening to detect atrial fibrillation or to prevent cardiovascular disease events in a pair... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 20, 2017 Category: Primary Care Source Type: news

Designing an Optimal Screening Program for Unknown AF Designing an Optimal Screening Program for Unknown AF
This study used computer simulations to determine an optimal age and evaluate the value of repeated screenings.Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 14, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Medical News Today: Ways to stop an AFib episode
A look at how to stop an atrial fibrillation (Afib) episode. Included is detail on the best ways to prevent an episode and when you should see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 13, 2017 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Medical News Today: Ways to stop an A-fib episode
A look at how to stop an atrial fibrillation (A-fib) episode. Included is detail on the best ways to prevent an episode and when you should see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 13, 2017 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Living with Atrial Fibrillation- Patient Experiences and Treatment
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - December 13, 2017 Category: Consumer Health News Source Type: news

Apixaban Ranks Highest for Stroke Prevention in Atrial Fibrillation Apixaban Ranks Highest for Stroke Prevention in Atrial Fibrillation
Apixaban ranks higher than other direct-acting oral anticoagulants (DOACs) for preventing stroke in patients with atrial fibrillation (AF), according to a network meta-analysis.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 12, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

With A-Fib, Urban Hospitals May Be a Better Bet
Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Health Disparities, Rural Health Concerns (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 11, 2017 Category: Consumer Health News Source Type: news

Atrial fibrillation may be caused by stress: Research shows yoga improves quality of life for sufferers by lowering heart rate, blood pressure
(Natural News) Atrial fibrillation is a cardiac rhythm disorder marked by the rapid and irregular beating of the atrium. Currently, there is no known cure for this condition, while management focuses on relief and prevention. Yet a study from 2016 has uncovered a new method of dealing with the symptoms of this condition: yoga. As... (Source: NaturalNews.com)
Source: NaturalNews.com - December 11, 2017 Category: Consumer Health News Source Type: news

ORBIT Bleeding Risk Score Performs Best in A - Fib
Findings based on comparison of four risk scores among atrial fibrillation patients (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 8, 2017 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Emergency Medicine, Nursing, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news

Can Cardiologist Care Really Improve Atrial Fibrillation Survival? Can Cardiologist Care Really Improve Atrial Fibrillation Survival?
A Canadian study has found that patients with new-onset atrial fibrillation live longer when cared for by cardiologists, but other twists in the data have experts urging caution in mandating such care.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 5, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Bristol-Myers Squibb and Pfizer Alliance urge people to 'Tune in to AFib, Take Note of Stroke Risk'
The Bristol-Myers Squibb and Pfizer Alliance, the National Stroke Association and iHeartMedia today launched 'Tune in to AFib, Take Note of Stroke Risk' to educate the estimated nearly seven million Americans in 2017 living with atrial fibrillation (AFib) not caused by a heart valve problem about their increased risk of stroke. (Source: World Pharma News)
Source: World Pharma News - December 5, 2017 Category: Pharmaceuticals Tags: Featured Bristol-Myers Squibb Business and Industry Source Type: news

FDA clears AliveCor ’ s KardiaBand ECG for Apple Watch
AliveCor said today that the FDA cleared its KardioBand electrocardiogram device for the Apple Watch, designed to monitor for early signs of atrial fibrillation. First introduced in March 2016, KardiaBand is the first medical device accessory to be cleared by the federal safety watchdog for the Apple Watch, Mountain View, Calif.-based AliveCor said. It’s designed to display and record clinical-grade cardiac rhythm readings in real time in about 30 seconds, the company said. AliveCor also said it launched the SmartRhythm artificial intelligence app for the Apple Watch, which is designed to continuously evalu...
Source: Mass Device - November 30, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Patient Monitoring Wall Street Beat AliveCor Cardiac Rhythm Management Source Type: news

Apple, Stanford launch Apple Heart Study to improve atrial fibrillation detection
The Apple Heart Study, an Apple Watch-based ResearchKit study using the heart rate sensor to look at potential arrhythmias, is launching today, the Cupertino tech giant told MobiHealthNews. (Source: mobihealthnews)
Source: mobihealthnews - November 30, 2017 Category: Information Technology Source Type: news

FDA Clears First Medical Device Accessory for Apple Watch(R)
AliveCor's KardiaBand™ allows users to take a 30 second EKG right on the wrist KardiaBand pairs with SmartRhythm™ in the Kardia Watch app to intelligently evaluate heart rate and physical activity, and instantly push notifications to take an EKG MOUN... Devices, Cardiology, FDA AliveCor, KardiaBand, Apple Watch, atrial fibrillation, SmartRhythm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 30, 2017 Category: Pharmaceuticals Source Type: news

Is Echocardiography Valid and Reproducible in AF? Is Echocardiography Valid and Reproducible in AF?
How accurate is echocardiography in identifying systolic and diastolic LV dysfunction in atrial fibrillation?Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 30, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Apixaban Scores Highest Among the DOACs in Meta-Analysis
Among direct-acting oral anticoagulants (DOACs), apixaban was rated most efficient at treating atrial fibrillation in a meta-analysis comparing the drugs with each other... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 30, 2017 Category: Primary Care Source Type: news

Mayo Clinic Q and A: Understanding and treating fibroelastomas
DEAR MAYO CLINIC:?I am an 83-year-old woman on warfarin because of atrial fibrillation, and I recently was diagnosed with a fibroelastoma.?Could you?give me a little information?on what this is, including the treatment and prognosis? ANSWER: Fibroelastomas are formally known as papillary fibroelastomas, or PFEs, and are sometimes called cardiac papillomas. These small, noncancerous tumors develop [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 28, 2017 Category: Databases & Libraries Source Type: news

Pradaxa ® (dabigatran etexilate) now approved in more than 100 countries for stroke prevention in atrial fibrillation
Pradaxa ® (dabigatran etexilate) now approved in more than 100 countries for stroke prevention in atrial fibrillation (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

10,000 patients with atrial fibrillation now enrolled in innovative GLORIA ™-AF Registry
10,000 patients with atrial fibrillation now enrolled in innovative GLORIA ™-AF Registry (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

FDA and EMA reaffirm important health benefits and safety of Pradaxa ® (dabigatran etexilate) for patients with atrial fibrillation
FDA and EMA reaffirm important health benefits and safety of Pradaxa ® (dabigatran etexilate) for patients with atrial fibrillation (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

Benefits of Pradaxa ® maintained in difficult to treat patients with atrial fibrillation and symptomatic heart failure
Benefits of Pradaxa ® maintained in difficult to treat patients with atrial fibrillation and symptomatic heart failure (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

New Pradaxa ® clinical study to explore practical management of patients with atrial fibrillation undergoing ablation
New Pradaxa ® clinical study to explore practical management of patients with atrial fibrillation undergoing ablation (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

Patients diagnosed with AF who seek cardiologist care more likely to survive first year
(Elsevier) Atrial fibrillation (AF) is growing to epidemic proportions worldwide. Investigators, hypothesizing that patients who received comprehensive cardiovascular care had a greater likelihood of survival during the first year following their initial diagnosis, found that cardiologist care was associated with a 32 percent lower death rate. However, views differ regarding whether this is a real effect requiring all AF patients to see a cardiologist, or an artifact of the study population. The study results are reported alongside an editorial in the Canadian Journal of Cardiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 27, 2017 Category: International Medicine & Public Health Source Type: news

How Medtronic & #039;s Pacemakers Are Now Harder to Hack
FDA approved Medtronic's Azure pacemakers, which feature the company's new BlueSync technology to protect patients from having their device hacked. The BlueSync technology is also now available with the Medtronic Percepta portfolio of quadripolar, MR-conditional cardiac resynchronization therapy pacemakers (CRT-Ps), the company said. BlueSync is intended to enable more secure wireless remote monitoring via Medtronic's CareLink Network, by limiting access to the device functionality and also by protecting patient data. Connected medical devices like pacemakers add value to patient care by enabling remote patient monito...
Source: MDDI - November 21, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Digital Health Cardiovascular Source Type: news

Medtronic wins FDA nod for Azure remote monitoring equipped pacers
Medtronic (NYSE:MDT) said today it won FDA approval for its portfolio of Azure pacemakers with BlueSync patient monitoring technology. The clearances cover both the Azure XT MRI and Azure S MRI pacers including single chamber and dual chamber models, the Fridley, Minn.-based company said. The newly cleared pacers have estimated lifespans of 13.7 years for dual chamber pacers, which Medtronic estimates is 27% longer than the earlier-gen devices. The Azure portfolio of pacers feature the company’s Reactive ATP algorithm intended to slow the progression of atrial fibrillation and BlueSynch technology which allows f...
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Medtronic Source Type: news

Mayo Clinic Minute: Research shows newer blood thinners have lower risk of kidney function decline
About 3 million Americans have atrial fibrillation (A-fib). And while blood thinners can drastically decrease their stroke risk, new research shows the drugs could damage their kidneys. People with A-fib often have problems with blood clots forming that can lead to strokes. To prevent the clots, health care providers generally prescribe these patients with anticoagulant [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 20, 2017 Category: Databases & Libraries Source Type: news

New RE-DUAL PCI Data: Dabigatran Dual Therapy Benefit Consistent New RE-DUAL PCI Data: Dabigatran Dual Therapy Benefit Consistent
The"reassuring" findings from the RE-DUAL PCI study were seen in several subgroups of patients with atrial fibrillation in a setting where they face an excess risk of bleeding with current triple antithrombotic therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Medical News Today: Chronic or persistent A-fib: What you need to know
Chronic atrial fibrillation can cause dizziness, heart palpitations, and fatigue. Learn more about this long-term cardiac condition. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 17, 2017 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Botox Injections to the Heart May Tamp Down Postop AF Botox Injections to the Heart May Tamp Down Postop AF
Epicardial injections of the neurotoxin appeared safe and reduced early postoperative atrial fibrillation by 11% compared with saline injections.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2017 Category: Cardiology Tags: Cardiology News Source Type: news

Anticoagulation in Patients With AF and Prior Hemorrhage Anticoagulation in Patients With AF and Prior Hemorrhage
Determining the optimal treatment approach for patients with atrial fibrillation who have had a brain hemorrhage remains extremely challenging. How can we balance risk vs. benefit?Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 15, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Clinical outcomes and history of fall in patients with atrial fibrillation treated with oral anticoagulation: insights from the ARISTOTLE Trial - Rao MP, Vinereanu D, Wojdyla DM, Alexander JH, Atar D, Hylek EM, Hanna M, Wallentin L, Lopes RD, Gersh BJ, Granger CB.
PURPOSE: We assessed outcomes among anticoagulated patients with atrial fibrillation (AF) and a history of falling, and whether the benefits of apixaban versus warfarin are consistent in this population. METHODS: Of the 18,201 patients in ARISTOTLE... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

BMS-Pfizer Alliance to unveil real-world data analyses - cost, safety and comparative effectiveness findings associated with oral anticoagulants in non-valvular atrial fibrillation
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) plan to release real-world data (RWD) analyses of outcomes associated with direct oral anticoagulants (DOAC) among non-valvular atrial fibrillation (NVAF) patients using the U.S. Medicare database - the nation's largest insurer handling more than one billion total claims per year(1) (Source: World Pharma News)
Source: World Pharma News - November 10, 2017 Category: Pharmaceuticals Tags: Featured Bristol-Myers Squibb Business and Industry Source Type: news

Being overweight taxes your heart, increasing risk of disease, death
(Natural News) A new study reveals that putting on extra weight can substantially alter the size of your heart, increasing the risk of heart attack or stroke. A bigger, heavier heart stretches its upper chambers, causing atrial fibrillation, or irregular heartbeats. The chances of you carrying excess weight is increased when you consume high amounts... (Source: NaturalNews.com)
Source: NaturalNews.com - November 10, 2017 Category: Consumer Health News Source Type: news

Planning to travel with atrial fibrillation?
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - November 8, 2017 Category: Consumer Health News Source Type: news

More active older women have lower mortality
Higher volumes and intensity of physical activity linked to lower mortality in older women Related items fromOnMedica Diet, lifestyle and cardiovascular disease Moderate exercise improves over-50s ’ brain health Never too old to benefit from CVD prevention Real food and brisk daily walk best for heart health Atrial fibrillation poses greater risk for women than men (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 7, 2017 Category: UK Health Source Type: news

Irregular heartbeat? THIS hidden heart condition has been linked to higher DEATH risk
AN IRREGULAR heartbeat is known as atrial fibrillation, and the common condition has been linked by researchers to a higher death risk in some sufferers. (Source: Daily Express - Health)
Source: Daily Express - Health - November 2, 2017 Category: Consumer Health News Source Type: news

TCT 2017: Boston Scientific touts lowered hemorrhagic stroke rate, cost for patients in Watchman studies
Boston Scientific (NYSE:BSX) today released combined 5-year outcomes data from both the Prevail and Protect-AF study of its Watchman left atrial appendage closure device, touting it as a safe and effective an alternative to long-term warfarin therapy for patients with non-valvular atrial fibrillation. Five-year data from the Prevail study was published online today in the Journal of the American College of Cardiology. In both trials, the Marlborough, Mass.-based company compared the Watchman device to warfarin treatment for stroke prevention in patients with non-valvular AF with follow-ups out to five years. A combine...
Source: Mass Device - November 2, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Boston Scientific Source Type: news